MYUNGMOON Pharm co.,Ltd (017180.KS) KSC

1,823.00

-27(-1.46%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap60.91B
Enterprise Value144.02B
P/E Ratio50.01
PEG Ratio0.38
Price/Sales Ratio0.32
Price/Book Ratio0.62
Enterprise/Revenue0.77
Enterprise/EBITDA4.27

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.04

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue186.44B
Revenue/Share5,723.47
Gross Profit104.97B
EBITDA5.67B
Net Income-3.03B
Diluted EPS-90.62

Balance Sheet

Total Cash6.7B
Total Cash/Share260.42
Total Debt96.23B
Total Debt/Equity0.97
Current Ratio0.98
Book Value Per Share3,130.82

Price History

52-Week Change0.89
52-Week High2,055
52-Week Low1,412
Moving Average 50 Days1,723.82
Moving Average 200 Days1,676.77

Statistics

Average Volume127,391
Shares Outstanding33.43M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor513:500
Last Split DateMay 14, 2020